Chronic treatment with olanzapine via a novel infusion pump induces adiposity in male rats

Life Sciences

Volumn 88, Issue 17-18, 2011, Pages 761-765

  Shobo, Miwako ^a   Yamada, Hiroshi ^a   Koakutsu, Akiko ^a   Hamada, Noritaka ^a   Fujii, Masahiro ^a   Harada, Katsuya ^a   Ni, Keni ^a   Matsuoka, Nobuya ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Antipsychotics; Body fat; Body weight; Chronic infusion; Food intake; Infusion pump; Male rat; Metabolic side effects; Olanzapine

Indexed keywords

OLANZAPINE;

ABDOMINAL FAT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; EPIDIDYMIS FAT; FOOD INTAKE; INFUSION PUMP; LONG TERM CARE; MALE; NONHUMAN; OBESITY; RAT; RETROPERITONEAL FAT; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BODY WEIGHT; EATING; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, SUBCUTANEOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 79954613933     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.02.014     Document Type: Article

References (30)

1. C. Abe, T. Tashiro, K. Tanaka, R. Ogihara, and H. Morita A novel type of implantable and programmable infusion pump for small laboratory animals J Pharmacol Toxicol Meth 59 2009 7 12
2. D.B. Allison, J.L. Mentore, M. Heo, L.P. Chandler, J.C. Cappelleri, and M.C. Infante Antipsychotic-induced weight gain: a comprehensive research synthesis Am J Psychiatry 156 1999 1686 1696 (Pubitemid 29517559)
3. T. Baptista Body weight gain induced by antipsychotic drugs: mechanisms and management Acta Psychiatr Scand 100 1999 3 16 (Pubitemid 29309192)
4. B.R. Basson, B.J. Kinon, C.C. Taylor, K.A. Szymanski, J.A. Gilmore, and G.D. Tollefson Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone J Clin Psychiatry 62 2001 231 238 (Pubitemid 32428761)
5. N. Bhana, R.H. Foster, R. Olney, and G.L. Plosker Olanzapine: an updated review of its use in the management of schizophrenia Drugs 61 2001 111 161 (Pubitemid 32108327)
6. M. Blouin, A. Tremblay, M.E. Jalbert, H. Venables, R.H. Bouchard, and M.A. Roy Adiposity and eating behaviors in patients under second generation antipsychotics Obesity (Silver Spring) 16 2008 1780 1787
7. J.T. Callaghan, R.F. Bergstrom, L.R. Ptak, and C.M. Beasley Olanzapine. Pharmacokinetic and pharmacodynamic profile Clin Pharmacokinet 37 1999 177 193
8. A.F. Chintoh, S.W. Mann, T.K. Lam, A. Giacca, and G. Remington Insulin resistance following continuous, chronic olanzapine treatment: an animal model Schizophr Res 104 2008 23 30
9. J.A. Chiu, and R.B. Franklin Analysis and pharmacokinetics of olanzapine (LY170053) and two metabolites in rat plasma using reversed-phase HPLC with electrochemical detection J Pharm Biomed Anal 14 1996 609 615 (Pubitemid 26161134)
10. S. Choi, B. DiSilvio, J. Unangst, and J.D. Fernstrom Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats Life Sci 81 2007 1024 1030 (Pubitemid 47384786)
11. G.D. Cooper, J.A. Harrold, J.C. Halford, and A.J. Goudie Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain Prog Neuropsychopharmacol Biol Psychiatry 32 2008 428 436 (Pubitemid 351178959)
12. G.D. Cooper, L.C. Pickavance, J.P. Wilding, J.A. Harrold, J.C. Halford, and A.J. Goudie Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities J Psychopharmacol 21 2007 405 413 (Pubitemid 47077303)
13. A.J. Goudie, G.D. Cooper, and J.C. Halford Antipsychotic-induced weight gain Diab Obes Metab 7 2005 478 487 (Pubitemid 41150421)
14. A.J. Goudie, J.A. Smith, and J.C. Halford Characterization of olanzapine-induced weight gain in rats J Psychopharmacol 16 2002 291 296 (Pubitemid 35470572)
15. S.H. Heil Sex-specific effects of prolactin on food intake by rats Horm Behav 35 1999 47 54 (Pubitemid 29100808)
16. S. Kapur, and D. Mamo Half a century of antipsychotics and still a central role for dopamine D2 receptors Prog Neuropsychopharmacol Biol Psychiatry 27 2003 1081 1090 (Pubitemid 37464954)
17. S. Kapur, S.C. VanderSpek, B.A. Brownlee, and J.N. Nobrega Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy J Pharmacol Exp Ther 305 2003 625 631 (Pubitemid 36459179)
18. S. Kapur, R.B. Zipursky, and G. Remington Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia Am J Psychiatry 156 1999 286 293 (Pubitemid 29077120)
19. M. Li, R. Budin, A.S. Fleming, and S. Kapur Effects of chronic typical and atypical antipsychotic drug treatment on maternal behavior in rats Schizophr Res 75 2005 325 336 (Pubitemid 40693065)
20. A.M. Meaney, and V. O'Keane Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia Life Sci 71 2002 979 992 (Pubitemid 34667104)
21. J. Minet-Ringuet, P.C. Even, M. Lacroix, D. Tome, and R. de Beaurepaire A model for antipsychotic-induced obesity in the male rat Psychopharmacology (Berl) 187 2006 447 454 (Pubitemid 44200516)
22. J. Minet-Ringuet, P.C. Even, P. Valet, C. Carpene, V. Visentin, and D. Prevot Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment Mol Psychiatry 12 2007 562 571 (Pubitemid 46816768)
23. A.P. Muller, A.H. Tort, J. Gnoatto, J.D. Moreira, E.R. Vinade, and M.L. Perry Metabolic and behavioral effects of chronic olanzapine treatment and cafeteria diet in rats Behav Pharmacol 21 2010 668 675
24. P.G. Reeves, F.H. Nielsen, and G.C. Fahey Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet J Nutr 123 1993 1939 1951 (Pubitemid 23342492)
25. M.A. Seager, V.N. Barth, L.A. Phebus, and K. Rasmussen Chronic coadministration of olanzapine and fluoxetine activates locus coeruleus neurons in rats: implications for bipolar disorder Psychopharmacology (Berl) 181 2005 126 133 (Pubitemid 41440923)
26. P. Turrone, G. Remington, S. Kapur, and J.N. Nobrega Continuous but not intermittent olanzapine infusion induces vacuous chewing movements in rats Biol Psychiatry 57 2005 406 411 (Pubitemid 40215771)
27. E.M. van der Zwaal, M.C. Luijendijk, R.A. Adan, and S.E. la Fleur Olanzapine-induced weight gain: chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution Eur J Pharmacol 585 2008 130 136
28. E.M. van der Zwaal, M.C. Luijendijk, S.S. Evers, S.E. la Fleur, and R.A. Adan Olanzapine affects locomotor activity and meal size in male rats Pharmacol Biochem Behav 97 2010 130 137
29. J.L. Volatier, and P. Verger Recent national French food and nutrient intake data Br J Nutr 81 Suppl. 2 1999 S57 S59
30. B. Woodside Prolactin and the hyperphagia of lactation Physiol Behav 91 2007 375 382 (Pubitemid 47016543)